Search concepts
|
Selected Filters
|
- 100 - 125 out of 252 results
Search results
-
Financial fallout from COVID-19: 38 hospitals laying off workers
8/24/20
1 item of Media coverage
Press/Media: Expert Comment
-
Doctors praise COVID-19 treatments, though much still to learn
8/20/20
1 item of Media coverage
Press/Media: Expert Comment
-
DOCTORS PRAISE COVID-19 TREATMENTS, THOUGH MUCH STILL TO LEARN
8/20/20
1 item of Media coverage
Press/Media: Expert Comment
-
VACCINE SMARTS-VOLUNTEERS VITAL IN FINDING EFFECTIVE COVID-19 VACCINE
8/19/20 → 8/20/20
2 items of Media coverage
Press/Media: Expert Comment
-
UTMB preparing to lay off nearly 200 employees due to Covid-19 pandemic
8/11/20
2 items of Media coverage
Press/Media: Expert Comment
-
UTMB preparing to lay off nearly 200 employees due to COVID-19 pandemic, president says
8/11/20
2 items of Media coverage
Press/Media: Expert Comment
-
With fewer elective surgeries and steep COVID-19 expenses, UTMB to cut 200 jobs
8/11/20
1 item of Media coverage
Press/Media: Expert Comment
-
Stillbirth Incidence Increases During COVID-19 Pandemic
7/20/20 → 7/22/20
3 items of Media coverage
Press/Media: Expert Comment
-
BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit Nasdaq:BSGM
John Manning, Cheng Huang & Slobodan Paessler
7/17/20 → 7/18/20
27 items of Media coverage
Press/Media: Expert Comment
-
Stillbirth incidence increases during COVID-19 pandemic
7/17/20
2 items of Media coverage
Press/Media: Expert Comment
-
A panel’s take on instruments, connectivity, COVID
7/16/20
1 item of Media coverage
Press/Media: Expert Comment
-
Opinion: Coronavirus Pandemic Highlights Dangers of Health Disparities
7/16/20
1 item of Media coverage
Press/Media: Expert Comment
-
A ‘catch and kill’ filter to control coronavirus indoors
William Lawrence & Slobodan Paessler
7/15/20
1 item of Media coverage
Press/Media: Expert Comment
-
Young people are leading the rise of COVID cases in Michigan. Here's what it means.
7/15/20
1 item of Media coverage
Press/Media: Expert Comment
-
BioSig Technologies: Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites
John Manning, Cheng Huang & Slobodan Paessler
7/13/20
1 item of Media coverage
Press/Media: Expert Comment
-
Opinion: Coronavirus Pandemic Highlights Dangers of Heath Disparities
7/13/20
1 item of Media coverage
Press/Media: Expert Comment
-
Phase II Human Trial Of ViralClear's Anti-Viral For SARS-CoV-2 Coronavirus Underway At 4 Key Trial Sites
John Manning, Cheng Huang & Slobodan Paessler
7/13/20
19 items of Media coverage
Press/Media: Expert Comment
-
Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites Nasdaq:BSGM
John Manning, Cheng Huang & Slobodan Paessler
7/13/20
1 item of Media coverage
Press/Media: Expert Comment
-
Virus strikes disproportionate blow in Latino community
7/12/20 → 7/13/20
2 items of Media coverage
Press/Media: Expert Comment
-
Coronavirus headlines: Where the pandemic is hitting Houston the hardest; More testing needed?
7/11/20
2 items of Media coverage
Press/Media: Expert Comment
-
Hispanic community being hit hardest by COVID-19
7/9/20
1 item of Media coverage
Press/Media: Expert Comment
-
ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19
John Manning, Cheng Huang & Slobodan Paessler
7/8/20 → 7/9/20
13 items of Media coverage
Press/Media: Expert Comment
-
ViralClear Pharmaceuticals Partners With Albany Molecular Research (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of COVID-19
John Manning, Cheng Huang & Slobodan Paessler
7/8/20
2 items of Media coverage
Press/Media: Expert Comment
-
ViralClear Pharmaceuticals Partners With Albany Molecular Research Inc. On The Manufacture Of Merimepodib Active Pharmaceutical Ingredient Development For The Potential Treatment Of COVID-19
John Manning, Cheng Huang & Slobodan Paessler
7/7/20 → 7/8/20
16 items of Media coverage
Press/Media: Expert Comment
-
ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19 Nasdaq:BSGM
John Manning, Cheng Huang & Slobodan Paessler
7/8/20
2 items of Media coverage
Press/Media: Expert Comment